An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study ...

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

WEIGHT loss jabs protect against dozens of illnesses but raise the chances of 19 others, a study shows. Demand has rocketed ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...